Global Information
회사소개 | 문의 | 비교리스트

세계의 동반진단 시장 : 예측과 기회(-2025년)

Global Companion Diagnostic Market By Technology, By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938721
페이지 정보 영문 119 Pages
가격
US $ 4,450 ₩ 5,094,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,239,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,819,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 동반진단 시장 : 예측과 기회(-2025년) Global Companion Diagnostic Market By Technology, By Products, By Indication, By End-User, By Application, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 119 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 동반진단 시장 규모는 2019년 30억 달러로 평가되었으며, 예측기간 동안 상당한 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다.

세계의 동반진단 (Companion Diagnostic) 시장을 부문별/지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 세계의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별(Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry 등)
    • 제품별(기기, 키트, 어세이)
    • 징후별(종양학, 호흡기, 정형외과 등)
    • 최종사용자별(제약 기업 및 바이오테크놀러지 기업, 연구소, 임상시험 수탁기관 등)
    • 용도별(신약, 체외진단 등)
    • 기업별
    • 지역별
  • 시장 매력 지수

제5장 아시아태평양의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 제품별
    • 징후별
    • 최종사용자별
    • 용도별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제6장 유럽의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 제품별
    • 징후별
    • 최종사용자별
    • 용도별
    • 국가별
  • 시장 매력 지수
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아

제7장 북미의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 제품별
    • 징후별
    • 최종사용자별
    • 용도별
    • 국가별
  • 시장 매력 지수
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 남미의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 제품별
    • 징후별
    • 최종사용자별
    • 용도별
    • 국가별
  • 시장 매력 지수
  • 남미 : 국가 분석
    • 브라질합니다
    • 아르헨티나
    • 콜롬비아

제9장 중동 및 아프리카의 동반진단 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 제품별
    • 징후별
    • 최종사용자별
    • 용도별
    • 국가별
  • 시장 매력 지수
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제10장 시장 역학

  • 성장 촉진요인
  • 과제

제11장 시장 동향과 발전

제12장 경쟁 상황

  • 경쟁 전망
  • 주요 기업 개요
    • NG Biotech
    • Agilent Technologies
    • Illumnia
    • Qiagen
    • Thermo Fisher Scientific
    • Roche
    • Molecular MD
    • Myriad Genetics
    • Foundation Medicine
    • Bayer
    • Genentech
    • Abbott
    • Novartis
    • Perkin Elmer
    • Luminex Corporation
    • Parexel
    • Quest Diagnostics
    • Genesys Diagnostics
    • Danaher
    • Siemens Healthcare
    • Biomerieux SA

제13장 전략적 권장사항

제14장 면책조항

LSH 20.06.19

Global companion diagnostic market size was valued at USD3 billion in 2019 and projected to grow at an impressive CAGR during the forecast period. The key factor responsible for the growth of companion diagnostic market is growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2025.

The global companion diagnostic market is segmented based on technology, products, indication, end-user, application, and region. Based on end user, the market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization and others. Out of which, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to widespread use of companion diagnostics in such industries because of their increasing stronghold in drug development sector as well as growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the global companion diagnostic market include NG Biotech, Agilent Technologies, Illumnia, Qiagen, Thermo Fisher Scientific, Roche, Molecular MD, Myriad Genetics, Foundation Medicine, Bayer, Genentech, Abbott, Novartis, Perkin Elmer, Luminex Corporation, Parexel, Quest Diagnostics, Genesys Diagnostics, Danaher, Siemens Healthcare, Biomerieux SA and others. The companies operating in global companion diagnostic market are focussing towards expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyse and forecast the market size of global companion diagnostic market.
  • To classify and forecast global companion diagnostic market based on technology, products, indication, end-user, application, company and regional distribution.
  • To identify drivers and challenges for global companion diagnostic market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global companion diagnostic market.
  • To conduct pricing analysis for global companion diagnostic market.
  • To identify and analyse the profile of leading players operating in global companion diagnostic market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, technologies and presence of all major players across the globe.

TechSci Research calculated the market size of global companion diagnostic market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global companion diagnostic market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Nanostring Technology

Next-Generation sequencing

In-Situ Hybridization

Immunohistochemistry

Others

  • Market, By Products:

Devices

Kits

Assay

  • Market, By Indication:

Oncology

Respiratory

Orthopedics

Others

  • Market, By End-User:

Pharmaceutical & Biotechnology Companies

Research Laboratories

Contract research organization

Others

  • Market, By Application:

Drug Discovery

In-Vitro diagnostics

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global companion diagnostic market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Companion Diagnostic Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technology (Nanostring Technology, Next-Generation sequencing, In-Situ Hybridization, Immunohistochemistry and Others)
    • 4.2.2. By Products (Devices, Kits and assay)
    • 4.2.3. By Indication (Oncology, Respiratory, Orthopedics and Others)
    • 4.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract research organization and others)
    • 4.2.5. By Application (Drug Discovery, In-Vitro diagnostics and Others)
    • 4.2.6. By Company (2019)
    • 4.2.7. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Companion Diagnostic Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
    • 5.2.2. By Products
    • 5.2.3. By Indication
    • 5.2.4. By End-User
    • 5.2.5. By Application
    • 5.2.6. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Companion Diagnostic Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Technology
        • 5.4.1.2.2. By Products
        • 5.4.1.2.3. By Indication
        • 5.4.1.2.4. By End-User
        • 5.4.1.2.5. By Application
    • 5.4.2. India Companion Diagnostic Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Technology
        • 5.4.2.2.2. By Products
        • 5.4.2.2.3. By Indication
        • 5.4.2.2.4. By End-User
        • 5.4.2.2.5. By Application
    • 5.4.3. Japan Companion Diagnostic Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Technology
        • 5.4.3.2.2. By Products
        • 5.4.3.2.3. By Indication
        • 5.4.3.2.4. By End-User
        • 5.4.3.2.5. By Application
    • 5.4.4. South Korea Companion Diagnostic Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Technology
        • 5.4.4.2.2. By Products
        • 5.4.4.2.3. By Indication
        • 5.4.4.2.4. By End-User
        • 5.4.4.2.5. By Application
    • 5.4.5. Singapore Companion Diagnostic Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Technology
        • 5.4.5.2.2. By Products
        • 5.4.5.2.3. By Indication
        • 5.4.5.2.4. By End-User
        • 5.4.5.2.5. By Application
    • 5.4.6. Australia Companion Diagnostic Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Technology
        • 5.4.6.2.2. By Products
        • 5.4.6.2.3. By Indication
        • 5.4.6.2.4. By End-User
        • 5.4.6.2.5. By Application

6. Europe Companion Diagnostic Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Products
    • 6.2.3. By Indication
    • 6.2.4. By End-User
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Companion Diagnostic Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Technology
        • 6.4.1.2.2. By Products
        • 6.4.1.2.3. By Indication
        • 6.4.1.2.4. By End-User
        • 6.4.1.2.5. By Application
    • 6.4.2. Germany Companion Diagnostic Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Technology
        • 6.4.2.2.2. By Products
        • 6.4.2.2.3. By Indication
        • 6.4.2.2.4. By End-User
        • 6.4.2.2.5. By Application
    • 6.4.3. United Kingdom Companion Diagnostic Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Technology
        • 6.4.3.2.2. By Products
        • 6.4.3.2.3. By Indication
        • 6.4.3.2.4. By End-User
        • 6.4.3.2.5. By Application
    • 6.4.4. Italy Companion Diagnostic Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Technology
        • 6.4.4.2.2. By Products
        • 6.4.4.2.3. By Indication
        • 6.4.4.2.4. By End-User
        • 6.4.4.2.5. By Application

7. North America Companion Diagnostic Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Products
    • 7.2.3. By Indication
    • 7.2.4. By End-User
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Companion Diagnostic Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Technology
        • 7.4.1.2.2. By Products
        • 7.4.1.2.3. By Indication
        • 7.4.1.2.4. By End-User
        • 7.4.1.2.5. By Application
    • 7.4.2. Mexico Companion Diagnostic Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Technology
        • 7.4.2.2.2. By Products
        • 7.4.2.2.3. By Indication
        • 7.4.2.2.4. By End-User
        • 7.4.2.2.5. By Application
    • 7.4.3. Canada Companion Diagnostic Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Technology
        • 7.4.3.2.2. By Products
        • 7.4.3.2.3. By Indication
        • 7.4.3.2.4. By End-User
        • 7.4.3.2.5. By Application

8. South America Companion Diagnostic Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Products
    • 8.2.3. By Indication
    • 8.2.4. By End-User
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Companion Diagnostic Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Technology
        • 8.4.1.2.2. By Products
        • 8.4.1.2.3. By Indication
        • 8.4.1.2.4. By End-User
        • 8.4.1.2.5. By Application
    • 8.4.2. Argentina Companion Diagnostic Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Technology
        • 8.4.2.2.2. By Products
        • 8.4.2.2.3. By Indication
        • 8.4.2.2.4. By End-User
        • 8.4.2.2.5. By Application
    • 8.4.3. Colombia Companion Diagnostic Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Technology
        • 8.4.3.2.2. By Products
        • 8.4.3.2.3. By Indication
        • 8.4.3.2.4. By End-User
        • 8.4.3.2.5. By Application

9. Middle East and Africa Companion Diagnostic Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Products
    • 9.2.3. By Indication
    • 9.2.4. By End-User
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Companion Diagnostic Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Technology
        • 9.4.1.2.2. By Products
        • 9.4.1.2.3. By Indication
        • 9.4.1.2.4. By End-User
        • 9.4.1.2.5. By Application
    • 9.4.2. Saudi Arabia Companion Diagnostic Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Technology
        • 9.4.2.2.2. By Products
        • 9.4.2.2.3. By Indication
        • 9.4.2.2.4. By End-User
        • 9.4.2.2.5. By Application
    • 9.4.3. UAE Companion Diagnostic Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Technology
        • 9.4.3.2.2. By Products
        • 9.4.3.2.3. By Indication
        • 9.4.3.2.4. By End-User
        • 9.4.3.2.5. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. NG Biotech
    • 12.2.2. Agilent Technologies
    • 12.2.3. Illumnia
    • 12.2.4. Qiagen
    • 12.2.5. Thermo Fisher Scientific
    • 12.2.6. Roche
    • 12.2.7. Molecular MD
    • 12.2.8. Myriad Genetics
    • 12.2.9. Foundation Medicine
    • 12.2.10. Bayer
    • 12.2.11. Genentech
    • 12.2.12. Abbott
    • 12.2.13. Novartis
    • 12.2.14. Perkin Elmer
    • 12.2.15. Luminex Corporation
    • 12.2.16. Parexel
    • 12.2.17. Quest Diagnostics
    • 12.2.18. Genesys Diagnostics
    • 12.2.19. Danaher
    • 12.2.20. Siemens Healthcare
    • 12.2.21. Biomerieux SA

13. Strategic Recommendations

14. About Us & Disclaimer

Back to Top
전화 문의
F A Q